454 Shares in Oracle Co. (NYSE:ORCL) Bought by Bellevue Group AG

Bellevue Group AG purchased a new position in shares of Oracle Co. (NYSE:ORCLFree Report) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 454 shares of the enterprise software provider’s stock, valued at approximately $48,000.

A number of other hedge funds have also bought and sold shares of ORCL. Vanguard Group Inc. raised its stake in shares of Oracle by 5.7% in the third quarter. Vanguard Group Inc. now owns 147,273,413 shares of the enterprise software provider’s stock valued at $15,599,200,000 after buying an additional 7,883,515 shares during the period. Northern Trust Corp raised its stake in shares of Oracle by 3.5% during the 3rd quarter. Northern Trust Corp now owns 18,718,180 shares of the enterprise software provider’s stock valued at $1,982,630,000 after purchasing an additional 635,994 shares during the period. Capital World Investors raised its stake in shares of Oracle by 22.1% during the 4th quarter. Capital World Investors now owns 18,384,162 shares of the enterprise software provider’s stock valued at $1,938,242,000 after purchasing an additional 3,323,334 shares during the period. Parnassus Investments LLC raised its stake in shares of Oracle by 17.7% during the 4th quarter. Parnassus Investments LLC now owns 14,599,902 shares of the enterprise software provider’s stock valued at $1,539,268,000 after purchasing an additional 2,191,342 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Oracle by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 11,909,069 shares of the enterprise software provider’s stock valued at $1,223,775,000 after purchasing an additional 204,546 shares during the period. 42.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Oracle

In other Oracle news, Director Michael J. Boskin sold 45,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $117.74, for a total transaction of $5,298,300.00. Following the completion of the transaction, the director now owns 87,473 shares of the company’s stock, valued at approximately $10,299,071.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Michael J. Boskin sold 45,000 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $117.74, for a total value of $5,298,300.00. Following the completion of the transaction, the director now owns 87,473 shares of the company’s stock, valued at approximately $10,299,071.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Safra Catz sold 790,000 shares of the stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $126.54, for a total value of $99,966,600.00. Following the completion of the transaction, the chief executive officer now directly owns 1,118,592 shares of the company’s stock, valued at approximately $141,546,631.68. The disclosure for this sale can be found here. Insiders sold 880,000 shares of company stock valued at $110,488,150 in the last 90 days. Insiders own 42.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ORCL. William Blair upgraded Oracle from a “market perform” rating to an “outperform” rating in a research note on Tuesday, March 12th. The Goldman Sachs Group boosted their price objective on Oracle from $115.00 to $130.00 and gave the company a “neutral” rating in a research note on Wednesday, March 13th. BMO Capital Markets boosted their price objective on Oracle from $126.00 to $142.00 and gave the company a “market perform” rating in a research note on Tuesday, March 12th. KeyCorp began coverage on Oracle in a research report on Thursday, March 21st. They set an “overweight” rating and a $150.00 target price for the company. Finally, Argus upgraded Oracle from a “hold” rating to a “buy” rating in a research report on Thursday, March 14th. Eleven research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $130.29.

View Our Latest Research Report on ORCL

Oracle Trading Down 0.6 %

NYSE ORCL opened at $123.70 on Tuesday. Oracle Co. has a 1-year low of $99.26 and a 1-year high of $132.77. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 13.34. The stock has a 50-day moving average of $120.19 and a 200-day moving average of $115.59. The firm has a market cap of $339.99 billion, a PE ratio of 32.64, a price-to-earnings-growth ratio of 2.60 and a beta of 1.01.

Oracle (NYSE:ORCLGet Free Report) last released its quarterly earnings results on Monday, March 11th. The enterprise software provider reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.04. The business had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.29 billion. Oracle had a return on equity of 336.11% and a net margin of 20.27%. Oracle’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.96 EPS. As a group, sell-side analysts forecast that Oracle Co. will post 4.44 EPS for the current year.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.